Moramide intermediate

Moramide intermediate (β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.

Moramide intermediate
Clinical data
Trade namesβ-Methyl-α,α-diphenyl-4-morpholinebutanoic acid
Other names4-Morpholinebutanoic acid, β-methyl-α,α-diphenyl-, moramide intermediate
Routes of
administration		N/A
ATC code
  • none
Legal status
Legal status
Identifiers
  • 3-Methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H25NO3
Molar mass339.435 g·mol−1
3D model (JSmol)
  • O=C(O)C(c1ccccc1)(c2ccccc2)C(C)CN3CCOCC3
  • InChI=1S/C21H25NO3/c1-17(16-22-12-14-25-15-13-22)21(20(23)24,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17H,12-16H2,1H3,(H,23,24)
  • Key:AWLNVHVUYACOMZ-UHFFFAOYSA-N

In the United States, moramide intermediate is designated as a Schedule II controlled substance,[2] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[3]

In Australia, moramide intermediate is listed as a Schedule 9 (Prohibited Substance)[4]

See also

References
  1. Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. Controlled Substances - by DEA Drug Code Number
  3. "DEA Diversion Control Division".
  4. "Therapeutic Goods (Poisons Standard—February 2024) Instrument 2024". Federal Register of Legislation. 23 January 2024. Retrieved 18 June 2024.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.